Literature DB >> 24898999

Acute psychosis with attention-deficit/hyperactivity disorder and oppositional-defiant disorder comorbidities.

Jonathan Ding1, Amin Muhammad Gadit1.   

Abstract

This is a case of an 18-year-old boy who presented with his mother in the emergency room with a 1-week history of paranoia and bizarre behaviour. His comorbidities included attention-deficit/hyperactivity disorder, oppositional-defiant disorder and mild intellectual delay. At the emergency room he was incoherent, agitated and uncooperative. He was admitted to the psychiatric inpatient unit and treated with low-dose risperidone. The patient's symptoms improved markedly over a few days, although he remained restless and had episodes of agitation. Nursing staff was concerned about his behaviour and found him difficult to manage. However, after speaking to the patient's family, this was felt to be his baseline. After 11 days the patient was discharged home in stable state. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24898999      PMCID: PMC4054492          DOI: 10.1136/bcr-2013-202835

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.

Authors:  J Biederman; J Newcorn; S Sprich
Journal:  Am J Psychiatry       Date:  1991-05       Impact factor: 18.112

Review 2.  Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.

Authors:  Markus Kraemer; Jennifer Uekermann; Jens Wiltfang; Bernhard Kis
Journal:  Clin Neuropharmacol       Date:  2010-07       Impact factor: 1.592

3.  The therapeutic alliance in cognitive-behavioral treatment of children referred for oppositional, aggressive, and antisocial behavior.

Authors:  Alan E Kazdin; Paul L Marciano; Moira K Whitley
Journal:  J Consult Clin Psychol       Date:  2005-08

Review 4.  The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review.

Authors:  Erik G Willcutt
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 5.  Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Authors:  Ronald T Brown; Robert W Amler; Wendy S Freeman; James M Perrin; Martin T Stein; Heidi M Feldman; Karen Pierce; Mark L Wolraich
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

Review 6.  Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents.

Authors:  Jonathan Ipser; Dan J Stein
Journal:  Psychopharmacology (Berl)       Date:  2006-09-16       Impact factor: 4.530

7.  Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.

Authors:  Tanya E Froehlich; Bruce P Lanphear; Jeffery N Epstein; William J Barbaresi; Slavica K Katusic; Robert S Kahn
Journal:  Arch Pediatr Adolesc Med       Date:  2007-09

8.  Prevalence and treatment of mental disorders among US children in the 2001-2004 NHANES.

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Debra Brody; Prudence W Fisher; Karen Bourdon; Doreen S Koretz
Journal:  Pediatrics       Date:  2009-12-14       Impact factor: 7.124

9.  Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders.

Authors:  O Stahlberg; H Soderstrom; M Rastam; C Gillberg
Journal:  J Neural Transm (Vienna)       Date:  2004-07       Impact factor: 3.575

10.  Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Authors:  Randal G Ross
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.